Bart van Hooland

Geotechnical Engineering and Marine Surveys (GEMS) is an independent group of companies providing geotechnical, geophysical, survey and metocean services around the world. Since its inception in 2004, GEMS has expanded rapidly and has international offices in the UK, Belgium, Nigeria, Egypt, Qatar and the UAE. The GEMS team includes professionally qualified geotechnical engineers, geophysicists, hydrographers and environmental scientists. With this diverse skillset, GEMS has the expertise to tailor make solutions to meet the diverse requirements of each of its clients, thereby providing innovative and highly competitive services. GEMS has successfully carried out projects for the Oil and Gas industry, government organizations, wind farms, cables/pipelines, dredging and harbours, client sectors. GEMS is dedicated to providing its clients with a completely integrated and tailored service. GEMS operates to ISO quality assurance standards and is also compliant with international legislation and safety standards.

Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands.

DROIA NV (DROIA) is an Independent Venture Capital firm founded in 2011 by Bart van Hooland. The firm is headquartered in Meise with additional office in Luxembourg.

Tusk Therapeutics SA develops and manufactures therapeutic products. The private company is based in Luxembourg, Luxembourg. and has subsidiaries in Belgium. Luc Dochez has been the CEO of the Luxembourger company since 2015.

Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom.

Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain.

Clair SARL engages in element roofing work.

Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium.

Part of Scala International, Scala Plastics NV is a Belgian company that wholesales building materials. The private company is based in Wetteren, Belgium. The company was founded in 1964. John Martens has been the CEO of the company since 2018.